Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic lupus erythematosus.

M C Hochberg1

  • 1Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Rheumatic Diseases Clinics of North America
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Multi-centre modified Delphi exercise to identify candidate items for classifying early-stage symptomatic knee osteoarthritis" [Osteoarthritis Cartilage (2025) 155-165].

Osteoarthritis and cartilage·2025
Same author

Multi-centre modified Delphi exercise to identify candidate items for classifying early-stage symptomatic knee osteoarthritis.

Osteoarthritis and cartilage·2024
Same author

Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial.

Osteoarthritis and cartilage·2023
Same author

Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status?

Osteoarthritis and cartilage open·2022
Same author

A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.

Osteoarthritis and cartilage·2021
Same author

Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over 2 years.

Osteoarthritis and cartilage·2020
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Systemic lupus erythematosus (SLE) affects Black individuals disproportionately. Research suggests a complex genetic and environmental cause, with improving patient outcomes over time.

Area of Science:

  • Epidemiology
  • Immunology
  • Genetics

Background:

  • Systemic lupus erythematosus (SLE) descriptive studies are global, with extensive data from Scandinavia and the United States.
  • In the U.S., Black populations exhibit threefold higher SLE incidence, prevalence, and mortality rates than White populations, with underlying reasons unidentified.

Purpose of the Study:

  • To review the epidemiology of SLE, focusing on incidence, prevalence, mortality, etiology, and prognosis.
  • To highlight the need for further research into non-infectious environmental triggers and quality of life improvements for SLE patients.

Main Methods:

  • Review of descriptive, analytic, and genetic epidemiologic studies on SLE.
  • Analysis of observational data on SLE prognosis and long-term morbidity.

Related Experiment Videos

Main Results:

  • SLE exhibits significant racial disparities in the U.S., with higher rates in Black individuals.
  • Evidence supports a multifactorial etiology for SLE, involving polygenic inheritance, autoimmune genes, and female sex hormones.
  • While viral causes are considered, environmental factors like chemical exposures are potential triggers.
  • SLE prognosis has improved, enabling better understanding of long-term health impacts.

Conclusions:

  • SLE etiology is complex, influenced by genetic and environmental factors.
  • Further research should investigate non-infectious environmental triggers.
  • Improving the quality of life for SLE patients is a critical future direction.